The University of Chicago Header Logo

Connection

Thomas N. Krausz to Administration, Oral

Back to Details
This is a "connection" page, showing publications Thomas N. Krausz has written about Administration, Oral.
Thomas N. Krausz
Connection Strength
0.021
Administration, Oral
  1. Foretinib (GSK1363089), an orally available multikinase inhibitor of c-Met and VEGFR-2, blocks proliferation, induces anoikis, and impairs ovarian cancer metastasis. Clin Cancer Res. 2011 Jun 15; 17(12):4042-51.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.